Compare companies

Pick 2–4 companies for a side-by-side spec sheet.

Selected: 1 / 4

Side by side

FieldBioAge Labs
Categories
drug-discoveryhealthcare
HQSan Francisco, California
Founded2017
Latest valuation$1B+ (post-IPO, 2025)
Annual Recurring Revenue (ARR)—
Funding to date$408M+ (Series D + IPO proceeds)
Headcount~150-200 (estimated)
ProfitabilityCash runway through 2029
Statusactive
Pricing tierenterprise
DescriptionAI-driven therapeutics company researching molecular pathways that contribute to aging and healthspan. Uses systems biology and machine learning trained on clinical and molecular data from thousands of patients to develop novel small-molecule therapeutics for aging-related diseases, oncology, and CNS disorders.